or Try an Advanced Search...

    Technical Analysis for TBPH - Theravance Biopharma, Inc.

    Grade Last Price % Change Price Change
    C 8.75 0.46% 0.04
    TBPH closed up 0.46 percent on Thursday, November 7, 2024, on 1.21 times normal volume. Its advance stalled at its 200 day moving average, an important long-term support / resistance line.
    Earnings due: Nov 12
    *** please verify all earnings dates ***
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Up Up
    Historical TBPH trend table...
    Date Alert Name Type % Chg
    200 DMA Resistance Bearish 0.00%
    Pocket Pivot Bullish Swing Setup 0.00%
    Up 3 Days in a Row Strength 0.00%
    Crossed Above 20 DMA Bullish 0.46%
    Stochastic Buy Signal Bullish 0.46%
    Pocket Pivot Bullish Swing Setup 0.46%
    Gapped Up Strength 0.46%
    Oversold Stochastic Weakness 0.46%
    Crossed Above 50 DMA Bullish 5.80%
    Lizard Bullish Bullish Day Trade Setup 5.80%
    Older End-of-Day Signals for TBPH ...

       Recent Intraday Alerts

    Alert Time
    60 Minute Opening Range Breakout about 2 hours ago
    Up 1% about 2 hours ago
    60 Minute Opening Range Breakdown about 7 hours ago
    Rose Above Previous Day's High about 8 hours ago
    10 DMA Support 1 day ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    TBPH Chart by TradingView
    Basic chart:

    Profile

    Theravance Biopharma, Inc. operates as a biopharmaceutical company. It provides discovery, development, and commercialization of small molecule medicines primarily for therapeutic areas of respiratory diseases, bacterial infections, and central nervous system (CNS)/pain. The company is based in George Town, Cayman Islands. Theravance Biopharma, Inc. operates as a subsidiary of Theravance Inc.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biopharmaceutical Pain Medication Respiratory Diseases Bacterial Infections

    Is TBPH a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Oct 24 Theravance Biopharma to Report Third Quarter 2024 Financial Results on November 12, 2024
    Oct 18 Theravance Announces Publication of YUPELRI® (revefenacin) Area Under the Curve Spirometry Analysis in the International Journal of Chronic Obstructive Pulmonary Disease
    Sep 10 Seth Klarman's Complete Exit from Theravance Biopharma Inc
    Sep 6 Why Is Madrigal (MDGL) Up 1% Since Last Earnings Report?
    Sep 6 Here's Why We're Not At All Concerned With Theravance Biopharma's (NASDAQ:TBPH) Cash Burn Situation
    Sep 4 Theravance Bio (TBPH) Up 2.2% Since Last Earnings Report: Can It Continue?
    Aug 14 Seth Klarman's Strategic Reduction in Theravance Biopharma Inc
    Aug 14 Klarman's Baupost adds WilScot, Capri, exits Altice USA, among others
    Aug 10 Need To Know: Analysts Just Made A Substantial Cut To Their Theravance Biopharma, Inc. (NASDAQ:TBPH) Estimates
    Aug 7 Theravance Biopharma Second Quarter 2024 Earnings: Misses Expectations
    See more TBPH news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 11.71
    52 Week Low 7.44
    Average Volume 178,678
    200-Day Moving Average 8.81
    50-Day Moving Average 8.28
    20-Day Moving Average 8.54
    10-Day Moving Average 8.49
    Average True Range 0.24
    RSI (14) 59.02
    ADX 22.09
    +DI 28.51
    -DI 15.28
    Chandelier Exit (Long, 3 ATRs) 8.20
    Chandelier Exit (Short, 3 ATRs) 8.61
    Upper Bollinger Bands 8.95
    Lower Bollinger Band 8.14
    Percent B (%b) 0.75
    BandWidth 9.56
    MACD Line 0.06
    MACD Signal Line 0.06
    MACD Histogram -0.0048
    Fundamentals Value
    Market Cap 435.73 Million
    Num Shares 49.8 Million
    EPS -1.03
    Price-to-Earnings (P/E) Ratio -8.50
    Price-to-Sales 7.89
    Price-to-Book 1.74
    PEG Ratio -0.05
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 9.02
    Resistance 3 (R3) 9.01 8.91 8.98
    Resistance 2 (R2) 8.91 8.84 8.92 8.96
    Resistance 1 (R1) 8.83 8.80 8.87 8.84 8.94
    Pivot Point 8.73 8.73 8.75 8.74 8.73
    Support 1 (S1) 8.65 8.66 8.69 8.66 8.56
    Support 2 (S2) 8.55 8.62 8.56 8.54
    Support 3 (S3) 8.47 8.55 8.53
    Support 4 (S4) 8.48